[The role of delta sleep-inducing peptide in the electric stability of the heart].
Zviaginsteva. M A MA
Key Findings
- Injecting DSIP (60 nM/kg) raised the threshold for ventricular fibrillation and related arrhythmias in rabbits.
- Neutralising DSIP with antiserum lowered those arrhythmia thresholds, indicating a protective role for the peptide.
- The authors propose that DSIP’s anti‑arrhythmic effect could explain its heart‑protective benefits under emotional stress.
Practical Outcomes
- While the results hint that DSIP could be a heart‑protective supplement, the evidence is limited to an animal model and no human dosing or safety data exist. Biohackers should view this as a preliminary finding that warrants more research before any real‑world protocol can be recommended.
Summary
A study in rabbits found that giving delta‑sleep‑inducing peptide (DSIP) made the heart more resistant to dangerous rhythms, while blocking the peptide made the heart more vulnerable. This suggests DSIP might help protect the heart during stress, but the work was done in animals and not in people.
Abstract
An experimental study in 38 rabbits explored the effect of delta-sleep peptide and its deficiency on thresholds of ventricular fibrillation or its precursors. The delta-sleep peptide (60 nM/kg) was shown to increase electric stability of the heart by elevating the thresholds of ventricular fibrillation and its precursors (ventricular extrasystoles and paroxysmal ventricular tachysystoles). Systemic deficiency of this peptide (the administration of antiserum T = 1:2000--1:3000, at 1:60 dilution) was, on the contrary, associated with lower ventricular arrhythmia thresholds. Therefore, delta-sleep peptide is shown to possess antiarrhythmic activity which may account for its protective cardiac effect under emotional stress.
Study Information
pubmed
1988